Table 5 Model 1 calibration at 3 years in the Asian population of the SEER database
From: Development of a prediction model for breast cancer based on the national cancer registry in Taiwan
Number of cases | Observed events | Predicted events | Difference (%) | P value | |
|---|---|---|---|---|---|
Subtype | |||||
Luminal-like | 854 | 13 | 15.03 | − 0.15 | 0.6 |
HER2 | 181 | 1 | 5.38 | − 4.38 | 0.059 |
Triple negative | 110 | 7 | 9.42 | − 0.34 | 0.431 |
Grade | |||||
1 | 261 | 0 | 1.52 | -Inf. | 0.218 |
2 | 538 | 4 | 11.55 | − 1.89 | 0.026 |
3 | 346 | 17 | 16.76 | 0.013 | 0.954 |
Pathological stage | |||||
1 | 577 | 0 | 3.04 | -Inf. | 0.081 |
2 | 457 | 7 | 14.35 | − 1.05 | 0.052 |
3 | 102 | 11 | 9.45 | 0.14 | 0.164 |
4 | 9 | 3 | 2.98 | 0.003 | 0.995 |
Chemotherapy | |||||
Without | 630 | 4 | 9.62 | − 1.4 | 0.07 |
With | 515 | 17 | 20.21 | − 0.19 | 0.474 |
Radiotherapy | |||||
Without | 397 | 10 | 11.15 | − 0.11 | 0.73 |
With | 748 | 11 | 18.68 | − 0.7 | 0.075 |
Age at diagnosis | |||||
< 35 | 17 | 1 | 0.53 | 0.46 | 0.522 |
35 to 49 | 333 | 7 | 7.54 | − 0.07 | 0.844 |
50 to 64 | 428 | 7 | 10.8 | − 0.54 | 0.247 |
65 to 74 | 206 | 3 | 5.59 | − 0.86 | 0.272 |
75+ | 161 | 3 | 5.37 | − 0.79 | 0.306 |
Tumor size | |||||
< 10 | 260 | 0 | 0.9 | -Inf. | 0.341 |
10 to 19 | 388 | 1 | 4.57 | − 3.57 | 0.095 |
20 to 29 | 257 | 5 | 6.73 | − 0.34 | 0.505 |
30 to 49 | 161 | 10 | 8.72 | 0.13 | 0.665 |
50+ | 79 | 5 | 8.92 | − 0.78 | 0.19 |